Extract

The purpose of this study is to assess the safety and pharmacokinetics, and determine the pediatric maximum tolerated dose and/or or recommended phase 2 dose of brentuximab vedotin.

Inclusion criteria

• relapsed or refractory Hodgkin Lymphoma ,Relapsed or Refractory Anaplastic Large-cell Lymphoma

Country

• France
• Germany
• Italy
• Mexico
• Netherlands
• Spain
• United Kingdom
• United States

Links

• ictrp
• nct